statistiche ricercatore

Continente	#
NA - Nord America	836
EU - Europa	679
AS - Asia	276
SA - Sud America	37
Continente sconosciuto - Info sul continente non disponibili	26
AF - Africa	8
Totale	1.862

Nazione	#
US - Stati Uniti d'America	822
DE - Germania	364
FI - Finlandia	212
SG - Singapore	130
CN - Cina	52
UA - Ucraina	31
HK - Hong Kong	28
BR - Brasile	25
VN - Vietnam	14
IN - India	13
FR - Francia	12
IT - Italia	11
TR - Turchia	11
IE - Irlanda	10
RU - Federazione Russa	10
SE - Svezia	8
GB - Regno Unito	7
AR - Argentina	6
PL - Polonia	5
BD - Bangladesh	4
BE - Belgio	4
JP - Giappone	4
ZA - Sudafrica	4
CA - Canada	3
IQ - Iraq	3
MX - Messico	3
PH - Filippine	3
PK - Pakistan	3
SA - Arabia Saudita	3
ES - Italia	2
HN - Honduras	2
MA - Marocco	2
VE - Venezuela	2
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
EC - Ecuador	1
GE - Georgia	1
GP - Guadalupe	1
IL - Israele	1
IR - Iran	1
KE - Kenya	1
KR - Corea	1
MF - Saint Martin	1
MN - Mongolia	1
NI - Nicaragua	1
NL - Olanda	1
OM - Oman	1
PE - Perù	1
PR - Porto Rico	1
PT - Portogallo	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	1.836

Nome	#
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study.	331
Activation of the endogenous interferon system, expression of interferon-alpha receptors, and response to interferon therapy in chronic hepatitis C	322
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship	263
Increase of Serum aú1-Acid Glycoprotein Despite the Decline of Liver Synthetic Function in Cirrhotics with Hepatocellular Carcinoma	247
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome	181
Changes in renal function following temporary occlusion of the thoracic duct	166
Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations	139
Prediction of jaundice by markers of inflammation in patients with liver disease	112
High prevalence of hepatitis G virus infection in patients with hepatocellular carcinoma	101
Totale	1.862

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	68	0	0	0	0	0	3	3	4	0	13	35	10
2022/2023	114	10	14	3	14	12	25	0	7	19	1	4	5
2023/2024	29	4	3	1	0	10	6	0	2	1	1	0	1
2024/2025	707	7	9	4	12	13	104	209	125	145	17	33	29
2025/2026	417	53	31	15	43	76	22	57	8	34	47	22	9
2026/2027	99	4	24	36	35	0	0	0	0	0	0	0	0
Totale													1.862